Expert Review of Pharmacoeconomics & Outcomes Research, Volume 22, Issue 8 (2022)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 22, Issue 8 (2022)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Volume 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Review

Review
Value assessment of new interventions for Alzheimer’s disease dementia in Japan based on literature review and group interview
Ataru Igarashi & Shunya Ikeda
Pages: 1163-1170
Published online: 01 Sep 2022
AbstractforValue assessment of new interventions for Alzheimer’s disease dementia in Japan based on literature review and group interview | Full Text | References | PDF (262.9 KB) | EPUB
  • 1239 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Systematic Review

Systematic Review
A systematic review of health state utility values in Thai cancer patients
Krittaphas Kangwanrattanakul
Pages: 1171-1186
Published online: 26 Sep 2022
AbstractforA systematic review of health state utility values in Thai cancer patients | Full Text | References | PDF (412.9 KB) | EPUB
  • 120 Views
  • 0 CrossRef citations
  • 0Altmetric
Systematic Review
Cost-effectiveness evaluation of mirabegron versus anti-muscarinics and third-line therapies: a systematic review
Ghader Mohammadnezhad, Behniya Azadmehr & Nazila Yousefi
Pages: 1187-1198
Published online: 07 Oct 2022
AbstractforCost-effectiveness evaluation of mirabegron versus anti-muscarinics and third-line therapies: a systematic review | Full Text | References | PDF (614.7 KB) | EPUB
  • 145 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
The impact of fibrodysplasia ossificans progressiva (FOP) on patients and their family members: results from an international burden of illness survey
Mona Al Mukaddam, Katherine S. Toder, Michelle Davis, Amanda Cali, Moira Liljesthröm, Suzanne Hollywood, Kim Croskery, Anne-Sophie Grandoulier, Elaine A. Böing, John D. Whalen & Frederick S. Kaplan
Pages: 1199-1213
Published online: 21 Sep 2022
AbstractforThe impact of fibrodysplasia ossificans progressiva (FOP) on patients and their family members: results from an international burden of illness survey | Full Text | References | PDF (4.2 MB) | EPUB | Supplemental
  • 3029 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Economic evaluation of doravirine/tenofovir disoproxil fumarate/lamivudine for HIV-1-infected adults in Russia: a cost-minimization and budget impact analysis
Elena Pyadushkina, Elena Derkach, Vladimir Rozenberg, Dzhumber Ugrekhelidze, Alena Lobodina, Carl Baxter & Andrew Beyer
Pages: 1215-1220
Published online: 05 Oct 2022
AbstractforEconomic evaluation of doravirine/tenofovir disoproxil fumarate/lamivudine for HIV-1-infected adults in Russia: a cost-minimization and budget impact analysis | Full Text | References | PDF (353.3 KB) | EPUB | Supplemental
  • 165 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Consumption of antidepressants and economic austerity in Brazil
Lívia Teixeira de Mattos, Claudia Garcia Serpa Osorio-de-Castro, Cláudia Du Bocage Santos-Pinto, Björn Wettermark & Carla Lourenço Tavares de Andrade
Pages: 1221-1229
Published online: 05 Sep 2022
AbstractforConsumption of antidepressants and economic austerity in Brazil | Full Text | References | PDF (1.7 MB) | EPUB
  • 67 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States
Qian Ding, Dane Shiltz, Dana Hossami & Alison M Konieczny
Pages: 1231-1241
Published online: 06 Sep 2022
AbstractforThe economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States | Full Text | References | PDF (969.9 KB) | EPUB
  • 164 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Design and testing of a health economic Markov model for treatment of anorexia nervosa
Vegard G Svendsen, Joran Lokkerbol, Unna N Danner, Alberte Jansingh, Silvia MAA Evers & Ben FM Wijnen
Pages: 1243-1251
Published online: 01 Sep 2022
AbstractforDesign and testing of a health economic Markov model for treatment of anorexia nervosa | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1218 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Evaluating reporting of patient-reported outcomes in peptic ulcer disease: a meta-epidemiological study of randomized controlled trials
Reece M. Anderson, Sam Streck, Griffin Hughes, Bethany Sutterfield, Micah Kee, Audrey Wise, Cody Hillman, Ryan Ottwell, Micah Hartwell & Matt Vassar
Pages: 1253-1260
Published online: 12 Sep 2022
AbstractforEvaluating reporting of patient-reported outcomes in peptic ulcer disease: a meta-epidemiological study of randomized controlled trials | Full Text | References | PDF (441.1 KB) | EPUB | Supplemental
  • 69 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Burden of disease of chronic pain in Colombia
Pieralessandro Lasalvia, Yaneth Gil-Rojas & Diego Rosselli
Pages: 1261-1267
Published online: 25 Sep 2022
AbstractforBurden of disease of chronic pain in Colombia | Full Text | References | PDF (809.5 KB) | EPUB | Supplemental
  • 366 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Indirect treatment comparison and cost-minimization analysis of riociguat versus selexipag in patients with pulmonary arterial hypertension
Eva Ornstová, Jan Tužil, Kateřina Chadimová, Tomáš Mlčoch & Tomáš Doležal
Pages: 1269-1275
Published online: 27 Sep 2022
AbstractforIndirect treatment comparison and cost-minimization analysis of riociguat versus selexipag in patients with pulmonary arterial hypertension | Full Text | References | PDF (477.7 KB) | EPUB | Supplemental
  • 393 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
The quality of published health economic evaluations on screening programs in China: a systematic review and quantitative appraisal
Yu Xia, Dai Lian, Yi Yang, Lei Si, Jian Ming, Yan Wei & Yingyao Chen
Pages: 1277-1283
Published online: 13 Oct 2022
AbstractforThe quality of published health economic evaluations on screening programs in China: a systematic review and quantitative appraisal | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 149 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease
Diana Mendes, Ahuva Averin, Mark Atwood, Reiko Sato, Andrew Vyse, James Campling, Derek Weycker, Mary Slack, Gillian Ellsbury & Tendai Mugwagwa
Pages: 1285-1295
Published online: 03 Nov 2022
AbstractforCost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease | Full Text | References | PDF (802.8 KB) | EPUB | Supplemental
  • 3237 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access

Explore articles